Philippe Jamme
Villejuif, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
International real-world study of combination immunotherapy sequences in metastatic melanoma.
Journal: Journal for immunotherapy of cancer
Published: October 08, 2025
Atypical anti-PD1-related leptomeningitis.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 28, 2025
Relevance of detection of RAF fusion transcripts in pan-negative melanoma in routine practice.
Journal: Melanoma research
Published: February 08, 2024
Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells.
Journal: Nature communications
Published: August 09, 2023
Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas.
Journal: Cancer immunology, immunotherapy : CII
Published: October 23, 2022
Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 29, 2022
MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)-dependent oncogenic driver in vitro and in humanised HGF knock-in mice.
Journal: Molecular oncology
Published: June 22, 2022
Unexpected cure of a toxic nodule in a multinodular goiter induced by immune checkpoint inhibitors: a case report.
Journal: European thyroid journal
Published: April 29, 2022
Response to BRAF and MEK Inhibitors in BRAF Thr599dup-Mutated Melanoma.
Journal: JCO precision oncology
Published: March 23, 2022
Response to Capmatinib in a MET Fusion-positive Cholangiocarcinoma.
Journal: The oncologist
Published: October 18, 2021
Last Updated: 09/26/2026